2024-02-28T15:56:48-06:00 2023-06-30 450250958 Eide Bailly LLP 800 Nicollet Mall Ste 1300 Minneapolis MN 554027033 990 2022-07-01 237455145 Healthwise Incorporated HEAL 2083451161 2601 N Bogus Basin Road Boise ID 83702 Elizabeth Beem CFO & Treasurer 2083451161 2024-02-26 1 Elizabeth Beem 999009999 1 Kim Hunwardsen CPA P00484560 6122536500 2024-02-26 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z Adam Husney MD CEO CM 2601 N Bogus Basin Road Boise ID 83702 56735048 0 X www.healthwise.org X 1975 ID To help people make better health decisions. 10 9 338 2 0 0 0 0 51237924 52199190 -6616910 871758 0 0 44621014 53070948 13742 9459 0 0 38656028 42634682 0 0 0 9788878 12002694 48458648 54646835 -3837634 -1575887 71816713 69780909 10358011 8755509 61458702 61025400 X The Healthwise mission is to help people make better health decisions. 0 0 46902456 9459 52199190 Everything Healthwise does is in support of their mission to help people make better health decisions. The focus is on getting the right information and tools to the right person at the right time to help them do three things critical to the improvement of health care in America:1. To help individuals provide as much care for themselves as they can. This includes medical self-care and wellness activities along with navigating the health care system.(Continued on Schedule O)2. To help individuals ask for the care they need. We give the patient plain-language guidelines for when medications, treatments and tests are recommended for specific medical conditions.3. To help them say "no" to care that is not right for them. It is often up to the patient to determine when the risks of a treatment outweigh the benefits.People turn to Healthwise information to learn how to do more for themselves, ask for the care they need, and say "no" to the care they don't need. Our mission is achieved every time an individual uses our information and tools to make better health decisions. 46902456 1 0 0 1 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 1 1 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 77 0 1 338 1 0 0 0 0 0 0 0 0 0 0 0 0 X 10 9 0 0 0 0 0 0 0 1 0 0 0 1 1 1 1 1 1 1 1 0 CA OR X Elizabeth Beem CFO & Treasurer 2083451161 2601 N Bogus Basin Road Boise ID 83702 A James Balkins III Chair of the Board 2.00 X X 3500 0 0 Margaret O'Kane Director 2.00 X 0 0 0 Evelyn Ho Vice Chair of the Board 2.00 X X 3500 0 0 Jamie Cooper Director 2.00 X 3000 0 0 Wanda K Nicholson MD Director 2.00 X 0 0 0 James R Bell Director 2.00 X 3500 0 0 David Rhew MD Director 2.00 X 2000 0 0 John Billings Director 2.00 X 2500 0 0 Richard Skinner Director 2.00 X 3000 0 0 Adam Husney MD Chief Executive & Medical Officer 50.00 X X 428239 0 172799 Cydni Waldner Chief Legal Officer & Secretary 50.00 X 281767 0 60170 Christine Calhoun Chief Content Officer 50.00 X 244766 0 56144 David Mink Chief Client Officer 50.00 X 287357 0 41266 Elizabeth Beem Chief Financial Officer & Treasurer 50.00 X 281116 0 58535 Katrina McDaniel Chief Human Resources Officer 50.00 X 238121 0 55465 Judith Marsh VP of Strategy 50.00 X 197693 0 43524 Thane Price VP of Technology 50.00 X 217014 0 52681 Alyson Erwin VP of Product 50.00 X 231751 0 50457 Andrew Binder Feb 22 - Jun 22 Chief Operating Officer 50.00 X 304642 0 9524 James Watkins VP of Sales 50.00 X 230759 0 23217 Brigid Runyon Account Executive 50.00 X 234551 0 14465 Heather Quinn Senior Medical Director 50.00 X 195327 0 21939 Matthias Berther VP of Privacy & Security 50.00 X 196520 0 50108 Stacy Sand VP of Marketing and Communications 50.00 X 214985 0 46713 3805608 0 757007 156 0 1 0 Experis US Inc 29973 Network Place Chicago IL 60673 External Engineering Resources 683254 In Time Tec LLC 580 E Corporate Dr Meridian ID 83642 External Engineering Resources 152000 Unstuck LLC 2009 Stebbins Rd Jefferson VT 05464 External Engineering Resources 139562 Triple C Ventures LLC 6057 E Gateway Dr Boise ID 83716 External Consulting 133333 4 Electronic Product Revenue 519200 51184433 51184433 Custom Product & Service Revenue 519200 1007931 1007931 6826 6826 52199190 993190 993190 3542668 3625356 38744 -82688 -38744 -121432 -121432 53070948 52199190 0 871758 2583 2583 6876 6876 3348444 1673223 1675221 30024856 26716600 3308256 1843937 1702675 141262 5078423 4528042 550381 2339022 2014189 324833 72229 72229 39204 39204 53962 53962 2498289 2023330 474959 101538 100588 950 20505 3453 17052 2712951 2349898 363053 382226 382226 527429 479751 47678 697265 191851 505414 403140 403140 419659 419659 UBIT Expense 10748 10748 Product Costs 3478222 3478222 Dues and Subscriptions 250741 173561 77180 Bad debt expense 172998 172998 161588 79591 81997 54646835 46902456 7744379 0 9115204 6190873 7078753 6854177 1391745 1913043 17005497 10298779 7076605 6706718 47154406 48116098 71816713 69780909 7598388 5775149 2759623 2980360 10358011 8755509 X 61458702 61025400 61458702 61025400 71816713 69780909 -1575887 1142585 0 X 0 1 X 1 0 X 5477364 5477364 47437833 48834788 48889363 51237924 52199190 248599098 47437833 48834788 54366727 51237924 52199190 254076462 0 14341063 13980283 12504970 13996163 15943774 70766253 14341063 13980283 12504970 13996163 15943774 70766253 183310209 517665 671012 779068 1221410 993190 4182345 27996 14275 25972 30347 0 98590 545661 685287 805040 1251757 993190 4280935 50000 50000 47983494 49570075 55171767 52489681 53192380 258407397 0.70940 0.71020 0.01660 0.01450 X Schedule A, Part III, Line 12, Explanation of Other Income: Rebate - 2019 Amount: $ 50,000. 0 61 61 46902395 46902456 1000000 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 108 61 169 250000 250000 250000 250000 1000000 1500000 1182827 1182827 12201402 6712139 5489263 3621268 3586640 34628 6706718 X 54252277 1142585 1142585 53109692 -38744 -38744 53070948 54685579 38744 38744 54646835 0 54646835 Part X, Line 2: The Organization believes that it has appropriate support for any tax positions taken affecting its annual filing requirements, and as such, does not have any uncertain tax positions that are material to the financial statements. The Organization would recognize future accrued interest and penalties related to unrecognized tax benefits and liabilities in income tax expense if such interest and penalties are incurred. Part XI, Line 4b - Other Adjustments: Foreign Exchange loss reported in expenses on financial statements. -38,744. Part XII, Line 2d - Other Adjustments: Foreign Exchange loss reported in expenses on financial statements. 38,744. Europe (Including Iceland & Greenland) 0 1 Program Services Health Information/Tools 38303 North America 0 1 Program Services Health Information/Tools 24682 East Asia and the Pacific 0 0 Program Services Legal Consulting, Health Information/Tools 8242 South America 0 0 Program Services Health Information/Tools 4200 0 2 0 0 0 2 75427 0 75427 0 0 0 0 0 0 Part I, line 3: Accrual method of accounting Part III Accounting Method: 1 Scholarships 2 6875 Part I, Line 2: Scholarship recipients furnish Healthwise with reports and tuition receipts prior to fund disbursement to confirm proper use of funds. X X X X 1 1 0 1 0 0 0 1 0 Adam Husney MD Chief Executive & Medical Officer 381351 0 46475 0 413 0 149618 0 23547 0 601404 0 0 0 Cydni Waldner Chief Legal Officer & Secretary 262141 0 19626 0 0 0 37550 0 22985 0 342302 0 0 0 Elizabeth Beem Chief Financial Officer & Treasurer 261379 0 19617 0 120 0 34948 0 23953 0 340017 0 0 0 David Mink Chief Client Officer 247296 0 39696 0 365 0 17679 0 23953 0 328989 0 0 0 Andrew Binder Feb 22 - Jun 22 Chief Operating Officer 124628 0 9750 0 170264 0 1827 0 7850 0 314319 0 0 0 Christine Calhoun Chief Content Officer 227419 0 17249 0 98 0 32557 0 23953 0 301276 0 0 0 Katrina McDaniel Chief Human Resources Officer 221088 0 16812 0 221 0 31878 0 23953 0 293952 0 0 0 Alyson Erwin VP of Product 217697 0 13833 0 221 0 26870 0 23953 0 282574 0 0 0 Thane Price VP of Technology 201346 0 15432 0 236 0 29094 0 23953 0 270061 0 0 0 Stacy Sand VP of Marketing and Communications 199835 0 15054 0 96 0 28240 0 18838 0 262063 0 0 0 James Watkins VP of Sales 198843 0 31282 0 634 0 14187 0 9396 0 254342 0 0 0 Brigid Runyon Account Executive 144990 0 89193 0 368 0 13737 0 1086 0 249374 0 0 0 Matthias Berther VP of Privacy & Security 182255 0 14121 0 144 0 26521 0 23953 0 246994 0 0 0 Judith Marsh VP of Strategy 183622 0 13514 0 557 0 25051 0 18838 0 241582 0 0 0 Heather Quinn Senior Medical Director 181442 0 13664 0 221 0 12909 0 9396 0 217632 0 0 0 Part I, Lines 4a-b Andrew Binder was Chief Operating Officer for Healthwise from February 1, 2022 until June 30, 2022. Under the terms of a Separation Agreement dated July 7, 2022, and in exchange for a general release of claims and a confidential and proprietary developments acknowledgement, Mr. Binder received a lump sum payment of $170,000, less applicable taxes. On October 23, 2020 the Organization entered into a retention agreement with its Chief Executive Officer (CEO) to provide incentive compensation to continue their employment with the Organization. Under the terms of this agreement, the Organization will pay the CEO a lump sum payment of $500,000 provided they remain employed by the Organization through November 1, 2025. Schedule J, Column C and Part VII, Section A, Form 990 include $100,000 of accrued compensation for the calendar year 2022. Part I, Line 5 In order for Healthwise to meet its mission of maximizing delivery of consumer health information and tools, Healthwise works with a variety of organizations that are active in the field of health education. In order to accomplish this exempt mission, a small number of employees are charged with the assignment of enhancing distribution through building relationships with these organizations. The compensation plans are designed to align sales incentive compensation with Healthwise's strategy to further the mission through new client acquisition. In developing the plan, Healthwise follows the principles of respect, teamwork, and do the right thing. These Healthwise employees' compensation is based partially on the results of their efforts tied to gross revenues received. None of the compensation is paid on net earnings. The setting of these employees' total compensation is reviewed carefully in comparison to market studies as benchmarks for reasonableness. Part I, Line 7 If the mission accomplishment is achieved, the Board considers the financial capabilities of Healthwise to pay such additional compensation so as not to jeopardize its operating ability, as well as reviews total compensation to assure that all compensation falls within the reasonable remuneration factors as a tax-exempt organization. Once the Board establishes if there will be a payment and determines the percentage of base pay used to calculate such payment or a base amount to pay each employee, then the formula used to determine the payment is applied to all employees, including officers. Certain officers of Healthwise are eligible for this additional compensation based on a multiplier of up to 2.0 times the Board approved percentage. Form 990, Part VI, Section A, line 8b There are no committees with broad authority to act on behalf of the board. Form 990, Part VI, Section B, line 11b Prior to filing the Form 990, the CEO, CFO, and Chief Legal Officer conduct a review and then each member of the Board of Directors is provided a copy of the Form 990 to review. The directors are encouraged to ask any questions regarding the filing and are given the opportunity to contact the CEO, CFO and/or Chief Legal Officer. If a regular board meeting is not scheduled prior to the filing, then at the discretion of the board, if they deem it advisable, a special meeting may be called to discuss the Form 990. Form 990, Part VI, Section B, line 12c All directors and officers are required to comply with the Healthwise conflict of interest policy during their employment or service. Annually, they are required to sign a statement affirming: they have read and understand the Healthwise Conflict of Interest Policy regarding interested persons/financial interest, agree to comply with the Policy, understand that Healthwise is a charitable organization and, to maintain its Federal tax exemption, it must engage primarily in activities that accomplish one or more of its tax-exempt purposes. This statement also requires they specify if they do or not have an actual or possible conflict of interest (as defined in the Policy) and if so, that they disclose this information. The Chief Legal Officer reviews the completed statements and presents any disclosed actual or possible conflicts of interest to the Board and/or Audit, Finance and Compensation Committee for review and a determination of whether a conflict exists, and if so, address such conflict. In addition, the Chief Legal Officer annually reviews with the Board and/or Audit, Finance and Compensation Committee transactions between Healthwise and organizations, which have an affiliation with a director or officer involving a financial interest (based on their completed statements) for a determination of whether a conflict exists and to seek approval or ratification of the transaction and its related agreements, as necessary. Form 990, Part VI, Section B, line 15 The following procedures are in place for setting and reviewing CEO, officers and key employees' compensation: 1. Compensation is reviewed and approved by the Audit, Finance and Compensation Committee (AFC Committee). Persons with conflicts of interest for a particular position are not involved in review or approval for such position. 2. Compensation is reviewed and approved using comparable compensation data provided by an independent compensation company for similarly qualified persons in functionally comparable positions at similarly situated organizations. The source data used is based on multiple compensation surveys. 3. There is contemporaneous documentation and record keeping with respect to the deliberations and decisions regarding the compensation arrangements. The documentation includes terms of compensation, members of the Committee/Board present for the decision and discussion, comparable data used and the basis for the decision made. 4. The Board has access to all AFC Committee decisions regarding the results of this process and, in addition, the Board directly handled the setting of the compensation for the CEO. 5. Additionally, the AFC Committee periodically engages independent compensation consultants to review and analyze total compensation for specific officer positions, and the terms and compensation relating to retention and incentive compensation agreements and severance plans, against survey and/or peer group data and/or industry and comparable benchmark data. In connection with these engagements, the AFC Committee generally seeks an opinion from the independent compensation consultant on the reasonableness of the compensation package and/or terms relating to the retention and/or incentive agreement or severance plan. The review, deliberation and approval specified in items 1-4 above along with the analysis and opinion of the independent compensation consultant was used by the AFC Committee and Board with regard to Plan compensation matters and compensation of the CEO. Form 990, Part VI, Section C, line 19 A copy of any of these documents, such as but not limited to, the Form 990, Articles of Incorporation, Bylaws, Conflict of Interest Policy and Financial Statements are available upon request from the CEO, Chief Legal Officer or the CFO's office.